Delivery Order SPE2DR25D2006-SPE2DR26F57EA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $11,897.40. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement with an ultimate completion date of November 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $75,786.23 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on December 19, 2025, with an ultimate completion date of December 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement needs. The contract performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Rifampin 300 mg capsules (60-count) with a contract ceiling value of $1,200.66. This is a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $3,619.94. This is a firm fixed-price delivery order with an ultimate completion date of November 5, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count) under a firm fixed-price contract valued at $1,586.94. The award, issued on December 17, 2025, with an ultimate completion date of December 18, 2025, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. Performance of this order will occur at the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $8,102.57. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-competitive set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Rifampin 300 mg capsules (60-count units) valued at $3,232.50 under firm fixed pricing. The order is non-set-aside and will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $31,201.41. This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Rifampin 150 mg capsules (30-count units) valued at $3,443.76. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively procured. The contract calls for performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $1,324.81. This firm fixed-price delivery order, with an ultimate completion date of November 14, 2025, was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's critical role as a pharmaceutical supplier to federal medical procurement. The place of...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F57EADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $3,384.52. This is a firm fixed-price delivery order with an ultimate completion date of January 8, 2026, and represents a non-set-aside competitive award. The work will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement. The company demonstrates significant capability in fulfilling government contracts for essential pharmaceutical commodities required by military treatment facilities and other federal healthcare institutions. The Rifampin order supports the Defense Health Agency and broader Department of Defense medical supply requirements, with the antibiotic medication being a standard treatment for bacterial infections including tuberculosis in military personnel and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 1/6/26 |